|
Name |
3,4-Dimethoxybenzamide
|
Molecular Formula | C9H11NO3 | |
IUPAC Name* |
3,4-dimethoxybenzamide
|
|
SMILES |
COC1=C(C=C(C=C1)C(=O)N)OC
|
|
InChI |
InChI=1S/C9H11NO3/c1-12-7-4-3-6(9(10)11)5-8(7)13-2/h3-5H,1-2H3,(H2,10,11)
|
|
InChIKey |
XNDZRGTVUVVHQT-UHFFFAOYSA-N
|
|
Synonyms |
3,4-Dimethoxybenzamide; 1521-41-1; Veratramide; Benzamide, 3,4-dimethoxy-; Veratrimidic acid; 3,4-Dimethoxy-benzamide; SEW9F1FKI8; MFCD00017128; NSC-370837; Veratramide; Veratrimidic acid; 3,4-Dimethoxybenzamide; NSC 370837; EINECS 216-190-5; NSC 370837; BRN 2646714; NSC370837; UNII-SEW9F1FKI8; Oprea1_176663; Oprea1_802187; 3-10-00-01427 (Beilstein Handbook Reference); SCHEMBL335681; CHEMBL505584; DTXSID1074549; ZINC298681; AMY28152; HY-N1777; AKOS000593686; SR-4191; AS-57779; SY275554; CS-0017631; FT-0656647; A809265; J-511211; Z33546772
|
|
CAS | 1521-41-1 | |
PubChem CID | 73705 | |
ChEMBL ID | CHEMBL505584 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 181.19 | ALogp: | 1.0 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 61.6 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.762 |
Caco-2 Permeability: | -4.714 | MDCK Permeability: | 0.00002290 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.405 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.353 |
Blood-Brain-Barrier Penetration (BBB): | 0.994 | Plasma Protein Binding (PPB): | 60.13% |
Volume Distribution (VD): | 1.034 | Fu: | 44.81% |
CYP1A2-inhibitor: | 0.678 | CYP1A2-substrate: | 0.907 |
CYP2C19-inhibitor: | 0.062 | CYP2C19-substrate: | 0.4 |
CYP2C9-inhibitor: | 0.021 | CYP2C9-substrate: | 0.665 |
CYP2D6-inhibitor: | 0.019 | CYP2D6-substrate: | 0.729 |
CYP3A4-inhibitor: | 0.019 | CYP3A4-substrate: | 0.252 |
Clearance (CL): | 7.909 | Half-life (T1/2): | 0.638 |
hERG Blockers: | 0.142 | Human Hepatotoxicity (H-HT): | 0.155 |
Drug-inuced Liver Injury (DILI): | 0.547 | AMES Toxicity: | 0.017 |
Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.084 | Carcinogencity: | 0.276 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.824 |
Respiratory Toxicity: | 0.023 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000478 | 0.750 | D02XJY | 0.400 | ||||
ENC000499 | 0.698 | D09GYT | 0.389 | ||||
ENC001055 | 0.634 | D0E6OC | 0.360 | ||||
ENC001056 | 0.634 | D0E9CD | 0.354 | ||||
ENC000501 | 0.585 | D0FN7J | 0.344 | ||||
ENC001363 | 0.560 | D0L0ZF | 0.341 | ||||
ENC001461 | 0.511 | D0VU8Q | 0.326 | ||||
ENC004830 | 0.469 | D06GCK | 0.316 | ||||
ENC000367 | 0.469 | D0Q9ON | 0.316 | ||||
ENC000296 | 0.457 | D06FPQ | 0.303 |